Lu Chen, PHD

Dr. Lu Chen has more than a decade of research & development and product development experience in the Cell and Gene Therapy space. She received her Ph.D. in Biomedical Sciences from Albert Einstein College of Medicine (Bronx, New York) in 2009.

Prior to joining Enochian BioSciences, Lu filled various scientific and leadership roles in the biotechnology and pharmaceutical industries. She worked at Atara Biotherapeutics as a Principal Scientist in the Process Sciences group and led the effort to develop a scale-up allogenic T cell manufacture platform for treating cancer and autoimmune diseases. As a Sr. Scientist at FUJIFILM Irvine Scientific, she led the Cell-based Technology team for Cell and Gene Therapy product development.

At Caladrius Biosciences, she was a Scientist and led the MOA study of a dendritic cell vaccine for melanoma treatment in a Phase III clinical trial. She also served as a post-doctoral fellow and project scientist at the University of California Irvine. She received multiple fellowship awards from the California Institute of Regenerative Medicine (CIRM) and National Institutes of Health (NIH) as a post-doctoral fellow and a graduate student.

Her significant work in both industry and academia has resulted in the development of several commercial products used in cell and gene therapy and publications in top peer-reviewed journals.

BACK